SUANFARMA enters into distribution license with Medisca to boost worldwide thyroid access
- SUANFARMA will now streamline distribution to Medisca’s supply of Thyroid Powder, USP to other channels and markets.
- Medisca remains the leading supplier of Thyroid Powder, USP to compounding pharmacies.
On March 16, 2022, SUANFARMA entered into an exclusive agreement with Medisca, a global supplier of pharmaceutical ingredients and equipment, for the distribution of Medisca’s supply of Thyroid Powder, USP, made possible by Medisca’s exclusive and robust partnership with Thyroid manufacturer, Sichuan Deebio Pharmaceutical Co., Ltd (Deebio).
“The quality standards set, transparency created, and commitment established between Medisca and Deebio, is what gave us the confidence in choosing Medisca as our primary supplier of Thyroid Powder, USP,” said Gustavo Adolfo Porras, Head of Sales, North America at SUANFARMA.
As an existent partner and supplier of ingredients to Medisca, for SUANFARMA, this agreement involved reinforcing a well-established symbiotic relationship between two companies committed to world-class quality, service, and price.
“After going to market, we immediately realized the demand for Thyroid Powder extended outside our direct distribution to compounding pharmacies,” said Panagiota Danopoulos, Senior Vice President of Global Strategy & Innovation at Medisca. “And we had the capacity to upscale supply to make this critical ingredient accessible to various markets, channels, and patients across the globe. A need we will now meet through our partnership with SUANFARMA.”
This agreement has the mission to drive forward worldwide access to qualified products through strategic partnerships aligned to the same standards of quality, consistency, and affordability.